Fingerprint
Dive into the research topics of 'A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia
Nitin Jain, William Wierda, Alessandra Ferrajoli, Franklin Wong, Susan Lerner, Michael Keating, Susan O'Brien
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations